Evidence map›Paper›PMID 40781540›Full record

ArticleCommunications biology2025

Rare variants and founder effect in the Beauce region of Quebec.

Mylène Gagnon, Claudia Moreau, Jasmin Ricard, Marie-Claude Boisvert, Alexandre Bureau, Michel Maziade, Simon L Girard

Abstract read
In one paragraph

Article in Communications biology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed.

  1. Article
  2. The Genetic and Molecular Analyses of Rare Candidate GermlineInternational journal of molecular sciences · 2026
    Article
  3. Article
  4. HeterozygousFrontiers in physiology · 2025
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Mylène GagnonDépartement des sciences fondamentales, Université du Québec à Chicoutimi, Saguenay, Québec, Canada.
Claudia MoreauDépartement des sciences fondamentales, Université du Québec à Chicoutimi, Saguenay, Québec, Canada.
Jasmin RicardCentre de recherche CERVO, Université Laval, Québec, Québec, Canada.
Marie-Claude BoisvertCentre de recherche CERVO, Université Laval, Québec, Québec, Canada.
Alexandre BureauCentre de recherche CERVO, Université Laval, Québec, Québec, Canada.
Michel MaziadeCentre de recherche CERVO, Université Laval, Québec, Québec, Canada.
Simon L GirardDépartement des sciences fondamentales, Université du Québec à Chicoutimi, Saguenay, Québec, Canada. simon2_girard@uqac.ca.ORCID http://orcid.org/0000-0002-4089-2280

Funding

Canada Research Chairs (Chaires de recherche du Canada) #950-200810Canada Research Chairs (Chaires de recherche du Canada) #CRC-2022-00444Gouvernement du Canada | Canadian Institutes of Health Research (Instituts de Recherche en Santé du Canada) #MOP-114988Gouvernement du Canada | Canadian Institutes of Health Research (Instituts de Recherche en Santé du Canada) #PCG-155471Gouvernement du Canada | Canadian Institutes of Health Research (Instituts de Recherche en Santé du Canada) #PJT-175122
6 · The paper itself

Abstract

Founder events influenced the genetic diversity within the province of Quebec, increasing the frequency of certain rare pathogenic variants in regional populations. Some regions, such as Beauce, remain understudied despite evidence of a regional founder effect. Leveraging extensive genealogical data, we observe a specific regional structure emerging in Beauce following the initial settlement. It is characterised by a gradual increase in inbreeding and kinship coefficients and a low diversity of ancestors. Taking advantage of the region's genetic distinctiveness, we describe 36 rare pathogenic variants with higher carrier rates in Beauce than in urban regions, likely due to the regional founder effect. This provides the first in-depth study of Beauce's genetic and genealogical landscape, revealing a distinct structure and suggesting that other overlooked regions, in Quebec and elsewhere, could benefit from fine-scale population structure studies to improve the understanding and management of rare diseases.

Indexed as

Founder EffectGenetic VariationRare DiseasesFemaleGenetics, PopulationHumansQuebec

Identifiers

PMID40781540
PMCPMC12334588

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.